A Host-Oriented Inhibitor of Junin Argentine Hemorrhagic Fever Virus Egress

There are currently no U.S. Food and Drug Administration (FDA)-approved vaccines or therapeutics to prevent or treat Argentine hemorrhagic fever (AHF). The causative agent of AHF is Junin virus (JUNV); a New World arenavirus classified as a National Institute of Allergy and Infectious Disease/Center...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lu, Jianhong, Han, Ziying, Liu, Yuliang, Liu, Wenbo, Lee, Michael S., Olson, Mark A., Ruthel, Gordon, Freedman, Bruce D., Harty, Ronald N.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2014
Materias:
Vaccines and Antiviral Agents
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3993831/
https://ncbi.nlm.nih.gov/pubmed/24522922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.03757-13
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares